{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:03:00Z","timestamp":1791554580797,"version":"4.3.4"},"reference-count":200,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22122706"],"award-info":[{"award-number":["22122706"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22377154"],"award-info":[{"award-number":["22377154"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Guangdong Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["2019QN01C125"],"award-info":[{"award-number":["2019QN01C125"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515010721"],"award-info":[{"award-number":["2024A1515010721"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024B1515040028"],"award-info":[{"award-number":["2024B1515040028"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2024A04J6478"],"award-info":[{"award-number":["2024A04J6478"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017688","name":"Guangdong Provincial Key Laboratory of Construction Foundation","doi-asserted-by":"publisher","award":["2023B1212060022"],"award-info":[{"award-number":["2023B1212060022"]}],"id":[{"id":"10.13039\/501100017688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jinorgbio.2026.113315","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:01:59Z","timestamp":1773457319000},"page":"113315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Anticancer gold complexes: Controlled activation, precision targeting and beyond"],"prefix":"10.1016","volume":"280","author":[{"given":"Yuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taotao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jinorgbio.2026.113315_bb0005","first-page":"209","article-title":"Conventional chemotherapy: millions of cures, unresolved therapeutic index","volume":"25","author":"de Letai","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.jinorgbio.2026.113315_bb0010","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/cncr.33933","article-title":"The cure of leukemia through the optimist\u2019s prism","volume":"128","author":"Kantarjian","year":"2022","journal-title":"Cancer"},{"issue":"17","key":"10.1016\/j.jinorgbio.2026.113315_bb0015","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1002\/cncr.30739","article-title":"Cancer-specific mortality, cure fraction, and noncancer causes of death among diffuse large B-cell lymphoma patients in the immunochemotherapy era","volume":"123","author":"Howlader","year":"2017","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113315_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-018-0029-0","article-title":"Testicular cancer","volume":"4","author":"Cheng","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-015-0439-8","article-title":"Progress in adjuvant chemotherapy for breast cancer: an overview","volume":"13","author":"Anampa","year":"2015","journal-title":"BMC Med."},{"issue":"6","key":"10.1016\/j.jinorgbio.2026.113315_bb0030","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1200\/JCO.2008.19.5362","article-title":"Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials","volume":"27","author":"Sargent","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.jinorgbio.2026.113315_bb0035","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"25","key":"10.1016\/j.jinorgbio.2026.113315_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202416396","article-title":"Reactive cysteines in proteins are the dominant reductants for platinum(IV) prodrug activation in live cells","volume":"64","author":"Chen","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113315_bb0045","doi-asserted-by":"crossref","first-page":"8879","DOI":"10.1038\/s41467-025-63958-2","article-title":"Harnessing platinum(IV) prodrugs as versatile photoinitiators and photocrosslinkers for multifunctional hydrogels and protein labeling","volume":"16","author":"Xu","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113315_bb0050","doi-asserted-by":"crossref","first-page":"9263","DOI":"10.1038\/s41467-025-64295-0","article-title":"Leveraging platinum-protein interactions to overcome chemoresistance","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.jinorgbio.2026.113315_bb0055","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1021\/acs.chemrev.5b00597","article-title":"The next generation of platinum drugs: targeted Pt(II) agents, nanoparticle delivery, and Pt(IV) prodrugs","volume":"116","author":"Johnstone","year":"2016","journal-title":"Chem. Rev."},{"issue":"9","key":"10.1016\/j.jinorgbio.2026.113315_bb0060","doi-asserted-by":"crossref","first-page":"9162","DOI":"10.1021\/acs.jmedchem.4c02509","article-title":"Platinum(IV) complexes trigger death receptors and natural killer cells to suppress breast cancer","volume":"68","author":"Cai","year":"2025","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.jinorgbio.2026.113315_bb0065","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1021\/acs.accounts.5b00203","article-title":"Functionalization of platinum complexes for biomedical applications","volume":"48","author":"Wang","year":"2015","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0070","doi-asserted-by":"crossref","unstructured":"Yang, T.; Zhang, S.; Yuan, H.; Wang, Y.; Cai, L.; Chen, H.; Wang, X.; Song, D.; Wang, X.; Guo, Z. Wang, X., Platinum-based TREM2 inhibitor suppresses tumors by remodeling the immunosuppressive microenvironment. Angew. Chem. Int. Ed. 2023, 62(2), e202213337.","DOI":"10.1002\/anie.202213337"},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113315_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/acs.jmedchem.4c01850","article-title":"Recent advances of metal complexes in the treatment of hepatocellular carcinoma","volume":"68","author":"Xu","year":"2025","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113315_bb0080","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/med.22021","article-title":"Metal complexes bearing EGFR-inhibiting ligands as promising anticancer agents","volume":"44","author":"Ma","year":"2024","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113315_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/acs.accounts.5c00471","article-title":"Molecular insights into bismuth\u2019s new applications against antimicrobial resistance and coronaviruses","volume":"59","author":"Li","year":"2026","journal-title":"Acc. Chem. Res."},{"issue":"15","key":"10.1016\/j.jinorgbio.2026.113315_bb0090","doi-asserted-by":"crossref","first-page":"12361","DOI":"10.1021\/jacs.4c16035","article-title":"Metal-based approaches for the fight against antimicrobial resistance: mechanisms, opportunities, and challenges","volume":"147","author":"Wang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.jinorgbio.2026.113315_bb0095","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jinorgbio.2007.11.003","article-title":"Gold(III) compounds as anticancer agents: relevance of gold\u2013protein interactions for their mechanism of action","volume":"102","author":"Casini","year":"2008","journal-title":"J. Inorg. Biochem."},{"issue":"23","key":"10.1016\/j.jinorgbio.2026.113315_bb0100","article-title":"The chemistry of anticancer mononuclear and N-bridged dinuclear 8-aminoquinoline half-sandwich metal complexes","volume":"31","author":"Steel","year":"2025","journal-title":"Chem"},{"issue":"23","key":"10.1016\/j.jinorgbio.2026.113315_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202505689","article-title":"A ruthenium(II) complex inhibits BRD4 for synergistic seno- and chemo-immunotherapy in cisplatin-resistant tumor cells","volume":"64","author":"Yang","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"issue":"3","key":"10.1016\/j.jinorgbio.2026.113315_bb0110","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1039\/C7CS00332C","article-title":"Structure\u2013activity relationships for ruthenium and osmium anticancer agents \u2013 towards clinical development","volume":"47","author":"Meier-Menches","year":"2018","journal-title":"Chem. Soc. Rev."},{"issue":"48","key":"10.1016\/j.jinorgbio.2026.113315_bb0115","doi-asserted-by":"crossref","first-page":"44356","DOI":"10.1021\/jacs.5c14772","article-title":"A sterically open ruthenium-based Photocage activated by red and far-red light for a wide range of drugs","volume":"147","author":"Husiev","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"43","key":"10.1016\/j.jinorgbio.2026.113315_bb0120","doi-asserted-by":"crossref","first-page":"23397","DOI":"10.1021\/jacs.3c01135","article-title":"Ruthenium-based Photoactivated chemotherapy","volume":"145","author":"Bonnet","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113315_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202514884","article-title":"Ruthenium complexes in protein science: heading a new generation of therapeutic and analytical tools","volume":"65","author":"Zhang","year":"2026","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0130","article-title":"Polypyridyl Ru(II) tamoxifen analogues: estrogen receptor-targeted dual photodynamic and chemotherapeutic agents","volume":"277","author":"Moreno-Alc\u00e1ntar","year":"2025","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2025.113145","article-title":"Employing phosphonate and phosphinate ligands for prodrug development of the mitochondrial calcium uniporter inhibitor Ru265","volume":"275","author":"Zou","year":"2026","journal-title":"J. Inorg. Biochem."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113315_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15010028","article-title":"Utilization of cancer cell line screening to elucidate the anticancer activity and biological pathways related to the ruthenium-based therapeutic BOLD-100","volume":"15","author":"Park","year":"2023","journal-title":"Cancers"},{"issue":"16_suppl","key":"10.1016\/j.jinorgbio.2026.113315_bb0145","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1200\/JCO.2024.42.16_suppl.4059","article-title":"Pankovich, J., A phase 2 study of BOLD-100 in combination with FOLFOX chemotherapy in patients with advanced gastric cancer: efficacy and safety analysis (BOLD-100-001)","volume":"42","author":"Spratlin","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.jinorgbio.2026.113315_bb0150","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1039\/C3SC53243G","article-title":"NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application","volume":"5","author":"Trondl","year":"2014","journal-title":"Chem. Sci."},{"issue":"24","key":"10.1016\/j.jinorgbio.2026.113315_bb0155","doi-asserted-by":"crossref","first-page":"8786","DOI":"10.1039\/C5CS00132C","article-title":"Chemical biology of anticancer gold(iii) and gold(i) complexes","volume":"44","author":"Zou","year":"2015","journal-title":"Chem. Soc. Rev."},{"issue":"11","key":"10.1016\/j.jinorgbio.2026.113315_bb0160","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1039\/C3DT52524D","article-title":"A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds","volume":"43","author":"Bertrand","year":"2014","journal-title":"Dalton Trans."},{"issue":"6","key":"10.1016\/j.jinorgbio.2026.113315_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.chempr.2025.102502","article-title":"Gold metallacages: design principles and applications","volume":"11","author":"Thomas","year":"2025","journal-title":"Chem"},{"issue":"11","key":"10.1016\/j.jinorgbio.2026.113315_bb0170","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.ccr.2009.02.019","article-title":"On the medicinal chemistry of gold complexes as anticancer drugs","volume":"253","author":"Ott","year":"2009","journal-title":"Coord. Chem. Rev."},{"issue":"25","key":"10.1016\/j.jinorgbio.2026.113315_bb0175","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2316615121","article-title":"Iridium(III) carbene complexes as potent girdin inhibitors against metastatic cancers","volume":"121","author":"Ruan","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2025.113179","article-title":"A cyclometalated iridium(III) complex with 2-acetylpyridine-N(4)-ortho-chlorophenyl thiosemicarbazone: potent antiproliferative and antibacterial activities","volume":"276","author":"Paes","year":"2026","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2025.113006","article-title":"Iridium(III) complexes as type I photosensitizers for hypoxic two-photon photodynamic therapy","volume":"272","author":"Tan","year":"2025","journal-title":"J. Inorg. Biochem."},{"issue":"18","key":"10.1016\/j.jinorgbio.2026.113315_bb0190","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1039\/D4SC01214C","article-title":"An iridium(iii)-based photosensitizer disrupting the mitochondrial respiratory chain induces ferritinophagy-mediated immunogenic cell death","volume":"15","author":"Feng","year":"2024","journal-title":"Chem. Sci."},{"issue":"9","key":"10.1016\/j.jinorgbio.2026.113315_bb0195","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1021\/cr980421n","article-title":"Structure, recognition, and processing of cisplatin-DNA adducts","volume":"99","author":"Jamieson","year":"1999","journal-title":"Chem. Rev."},{"issue":"2\u20133","key":"10.1016\/j.jinorgbio.2026.113315_bb0200","article-title":"The chemistry of gold drugs","volume":"1","author":"Sadler","year":"1994","journal-title":"Metal-Based Drugs"},{"issue":"30","key":"10.1016\/j.jinorgbio.2026.113315_bb0205","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1002\/anie.200600112","article-title":"A Spiropyran-based Ensemble for Visual Recognition and Quantification of cysteine and homocysteine at physiological levels","volume":"45","author":"Shao","year":"2006","journal-title":"Angew. Chem. Int. Ed."},{"issue":"41","key":"10.1016\/j.jinorgbio.2026.113315_bb0210","doi-asserted-by":"crossref","first-page":"7766","DOI":"10.1039\/c0cc02381g","article-title":"Rhodamine\u2013sugar based turn-on fluorescent probe for the detection of cysteine and homocysteine in water","volume":"46","author":"Yang","year":"2010","journal-title":"Chem. Commun."},{"issue":"6","key":"10.1016\/j.jinorgbio.2026.113315_bb0215","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1039\/b925092a","article-title":"Fluorescent and colorimetric probes for detection of thiols","volume":"39","author":"Chen","year":"2010","journal-title":"Chem. Soc. Rev."},{"issue":"6","key":"10.1016\/j.jinorgbio.2026.113315_bb0220","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1039\/c2sc01127a","article-title":"A spontaneous gold(i)-azide alkyne cycloaddition reaction yields gold-peptide bioconjugates which overcome cisplatin resistance in a p53-mutant cancer cell line","volume":"3","author":"K\u00f6ster","year":"2012","journal-title":"Chem. Sci."},{"issue":"11","key":"10.1016\/j.jinorgbio.2026.113315_bb0225","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.ccr.2009.02.026","article-title":"Thioredoxin reductase: a target for gold compounds acting as potential anticancer drugs","volume":"253","author":"Bindoli","year":"2009","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103245","article-title":"The rheumatoid arthritis drug auranofin exerts potent anti-lymphoma effect by stimulating TXNRD-mediated ROS generation and inhibition of energy metabolism","volume":"75","author":"Yang","year":"2024","journal-title":"Redox Biol."},{"issue":"49","key":"10.1016\/j.jinorgbio.2026.113315_bb0235","doi-asserted-by":"crossref","first-page":"20536","DOI":"10.1021\/jacs.0c09753","article-title":"Rationally designed redox-active au(I) N-heterocyclic Carbene: An immunogenic cell death inducer","volume":"142","author":"Sen","year":"2020","journal-title":"J. Am. Chem. Soc."},{"issue":"36","key":"10.1016\/j.jinorgbio.2026.113315_bb0240","doi-asserted-by":"crossref","first-page":"10779","DOI":"10.1039\/D2SC03756D","article-title":"BQ-AurIPr: a redox-active anticancer au(i) complex that induces immunogenic cell death","volume":"13","author":"Mule","year":"2022","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101949","article-title":"Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer","volume":"42","author":"Freire Boullosa","year":"2021","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113315_bb0250","article-title":"Ligand supplementation restores the cancer therapy efficacy of the antirheumatic drug auranofin from serum inactivation","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.jinorgbio.2026.113315_bb0255","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1021\/acs.jmedchem.4c02252","article-title":"Dual-targeting TrxR-EGFR Alkynyl-au(I) Gefitinib complex induces Ferroptosis in Gefitinib-resistant lung Cancer via degradation of GPX4","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113315_bb0260","article-title":"Auranofin mitigates systemic iron overload and induces ferroptosis via distinct mechanisms","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113315_bb0265","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/anie.201509612","article-title":"Anticancer gold(III) porphyrins target mitochondrial chaperone Hsp60","volume":"55","author":"Hu","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"issue":"3","key":"10.1016\/j.jinorgbio.2026.113315_bb0270","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1073\/pnas.1915202117","article-title":"An anticancer gold(III)-activated porphyrin scaffold that covalently modifies protein cysteine thiols","volume":"117","author":"Tong","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.jinorgbio.2026.113315_bb0275","first-page":"5486","article-title":"In vivo antitumor activity and in vitro cytotoxic properties of Bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride","volume":"46","author":"Berners-Price","year":"1986","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.jinorgbio.2026.113315_bb0280","doi-asserted-by":"crossref","first-page":"14424","DOI":"10.1021\/acs.jmedchem.2c00737","article-title":"Design, synthesis, and preclinical activity in ovarian cancer models of new phosphanegold(I)-N-heterocyclic carbene complexes","volume":"65","author":"Sulaiman","year":"2022","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.jinorgbio.2026.113315_bb0285","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1039\/D1DT03546K","article-title":"A novel cyclic dinuclear gold(I) complex induces anticancer activity via an oxidative stress-mediated intrinsic apoptotic pathway in MDA-MB-231 cancer cells","volume":"51","author":"Abogosh","year":"2022","journal-title":"Dalton Trans."},{"issue":"12","key":"10.1016\/j.jinorgbio.2026.113315_bb0290","doi-asserted-by":"crossref","first-page":"8401","DOI":"10.1021\/acs.jmedchem.2c00300","article-title":"Biotin-targeted au(I) radiosensitizer for cancer synergistic therapy by intervening with redox homeostasis and inducing ferroptosis","volume":"65","author":"Yang","year":"2022","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113315_bb0295","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1021\/acsptsci.9b00107","article-title":"Auranofin-based analogues are effective against clear cell renal carcinoma in vivo and display no significant systemic toxicity","volume":"3","author":"Elie","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"36","key":"10.1016\/j.jinorgbio.2026.113315_bb0300","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1002\/anie.200601526","article-title":"Luminescence studies of the intracellular distribution of a Dinuclear gold(I) N-heterocyclic Carbene complex","volume":"45","author":"Barnard","year":"2006","journal-title":"Angew. Chem. Int. Ed."},{"issue":"9","key":"10.1016\/j.jinorgbio.2026.113315_bb0305","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/anie.201400280","article-title":"Corrigendum: metal\/N-heterocyclic Carbene complexes: opportunities for the development of anticancer Metallodrugs","volume":"53","author":"Cisnetti","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"issue":"38","key":"10.1016\/j.jinorgbio.2026.113315_bb0310","doi-asserted-by":"crossref","first-page":"12570","DOI":"10.1021\/ja804027j","article-title":"Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols","volume":"130","author":"Hickey","year":"2008","journal-title":"J. Am. Chem. Soc."},{"issue":"48","key":"10.1016\/j.jinorgbio.2026.113315_bb0315","doi-asserted-by":"crossref","first-page":"15042","DOI":"10.1021\/ja075889z","article-title":"Anticancer and antimicrobial metallopharmaceutical agents based on palladium, gold, and silver N-heterocyclic carbene complexes","volume":"129","author":"Ray","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0320","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ccr.2016.09.004","article-title":"Update on metal N-heterocyclic carbene complexes as potential anti-tumor metallodrugs","volume":"329","author":"Liu","year":"2016","journal-title":"Coord. Chem. Rev."},{"issue":"31","key":"10.1016\/j.jinorgbio.2026.113315_bb0325","doi-asserted-by":"crossref","first-page":"8889","DOI":"10.1002\/anie.201602702","article-title":"N-heterocyclic carbene-gold(I) complexes conjugated to a leukemia-specific DNA aptamer for targeted drug delivery","volume":"55","author":"Niu","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"issue":"13","key":"10.1016\/j.jinorgbio.2026.113315_bb0330","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1002\/anie.201511999","article-title":"Determinants for tight and selective binding of a medicinal dicarbene gold(I) complex to a telomeric DNA G-quadruplex: a joint ESI MS and XRD investigation","volume":"55","author":"Bazzicalupi","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"issue":"15","key":"10.1016\/j.jinorgbio.2026.113315_bb0335","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1039\/C5CC09718E","article-title":"Versatile synthesis of cationic N-heterocyclic carbene-gold(i) complexes containing a second ancillary ligand. Design of heterobimetallic ruthenium-gold anticancer agents","volume":"52","author":"Fern\u00e1ndez-Gallardo","year":"2016","journal-title":"Chem. Commun."},{"issue":"44","key":"10.1016\/j.jinorgbio.2026.113315_bb0340","doi-asserted-by":"crossref","first-page":"14524","DOI":"10.1002\/anie.201805727","article-title":"On the mechanism of gold\/NHC compounds binding to DNA G-Quadruplexes: combined Metadynamics and biophysical methods","volume":"57","author":"Wragg","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"issue":"29","key":"10.1016\/j.jinorgbio.2026.113315_bb0345","doi-asserted-by":"crossref","first-page":"12062","DOI":"10.1002\/anie.202002992","article-title":"An Artemisinin-Derivative-(NHC)Gold(I) Hybrid with enhanced cytotoxicity through inhibition of NRF2 transcriptional activity","volume":"59","author":"Zhang","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"issue":"39","key":"10.1016\/j.jinorgbio.2026.113315_bb0350","doi-asserted-by":"crossref","first-page":"17130","DOI":"10.1002\/anie.202008046","article-title":"(124) I radiolabeling of a au(III) -NHC complex for in vivo biodistribution studies","volume":"59","author":"Guarra","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113315_bb0355","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1021\/jacs.2c09820","article-title":"Encapsulation of gold-based anticancer agents in protease-degradable peptide Nanofilaments enhances their potency","volume":"145","author":"Marciano","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"10.1016\/j.jinorgbio.2026.113315_bb0360","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1039\/c1cs15123a","article-title":"Applications of gold(I) alkynyl systems: a growing field to explore","volume":"40","author":"Lima","year":"2011","journal-title":"Chem. Soc. Rev."},{"issue":"35","key":"10.1016\/j.jinorgbio.2026.113315_bb0365","doi-asserted-by":"crossref","first-page":"8895","DOI":"10.1002\/anie.201202939","article-title":"On the biological properties of alkynyl phosphine gold(I) complexes","volume":"51","author":"Meyer","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"issue":"8","key":"10.1016\/j.jinorgbio.2026.113315_bb0370","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1002\/anie.202013366","article-title":"Bioorthogonal activation of dual catalytic and anti-Cancer activities of Organogold(I) complexes in living systems","volume":"60","author":"Long","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"issue":"11","key":"10.1016\/j.jinorgbio.2026.113315_bb0375","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1039\/C4SC01684J","article-title":"Luminescent re(i) and re(i)\/au(i) complexes as cooperative partners in cell imaging and cancer therapy","volume":"5","author":"Fern\u00e1ndez-Moreira","year":"2014","journal-title":"Chem. Sci."},{"issue":"38","key":"10.1016\/j.jinorgbio.2026.113315_bb0380","doi-asserted-by":"crossref","first-page":"16795","DOI":"10.1002\/anie.202006212","article-title":"A multitarget gold(I) complex induces cytotoxicity related to aneuploidy in HCT-116 colorectal carcinoma cells","volume":"59","author":"Zhang","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113315_bb0385","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/187152010791162298","article-title":"Latest insights into the anticancer activity of gold(III)-dithiocarbamato complexes","volume":"10","author":"Ronconi","year":"2010","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"22","key":"10.1016\/j.jinorgbio.2026.113315_bb0390","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.1039\/D0DT01411G","article-title":"Highly cytotoxic gold(i)-phosphane dithiocarbamate complexes trigger an ER stress-dependent immune response in ovarian cancer cells","volume":"49","author":"Le","year":"2020","journal-title":"Dalton Trans."},{"issue":"11","key":"10.1016\/j.jinorgbio.2026.113315_bb0395","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1039\/C8MT00225H","article-title":"Cyclometallated au(iii) dithiocarbamate complexes: synthesis, anticancer evaluation and mechanistic studies","volume":"10","author":"Williams","year":"2018","journal-title":"Metallomics"},{"issue":"2","key":"10.1016\/j.jinorgbio.2026.113315_bb0400","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ijc.25684","article-title":"Gold(III)-dithiocarbamato anticancer agents: activity, toxicology and histopathological studies in rodents","volume":"129","author":"Marzano","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"21","key":"10.1016\/j.jinorgbio.2026.113315_bb0405","doi-asserted-by":"crossref","first-page":"10478","DOI":"10.1158\/0008-5472.CAN-06-3017","article-title":"A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts","volume":"66","author":"Milacic","year":"2006","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.jinorgbio.2026.113315_bb0410","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/cmdc.201800098","article-title":"Anticancer gold(III) Peptidomimetics: from synthesis to in vitro and ex vivo biological evaluations","volume":"13","author":"Boscutti","year":"2018","journal-title":"ChemMedChem"},{"issue":"9","key":"10.1016\/j.jinorgbio.2026.113315_bb0415","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1039\/C5SC01753J","article-title":"Heterometallic titanium-gold complexes inhibit renal cancer cells in vitro and in vivo","volume":"6","author":"Fern\u00e1ndez-Gallardo","year":"2015","journal-title":"Chem. Sci."},{"issue":"31","key":"10.1016\/j.jinorgbio.2026.113315_bb0420","doi-asserted-by":"crossref","first-page":"8122","DOI":"10.1002\/anie.201403651","article-title":"A cyclization\u2013rearrangement cascade for the synthesis of structurally complex chiral gold(I)\u2013aminocarbene complexes","volume":"53","author":"Kolund\u017ei\u0107","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"issue":"25","key":"10.1016\/j.jinorgbio.2026.113315_bb0425","doi-asserted-by":"crossref","first-page":"7102","DOI":"10.1002\/anie.201702135","article-title":"Solution NMR structure of a ligand\/Hybrid-2-G-Quadruplex complex reveals rearrangements that affect ligand binding","volume":"56","author":"Wirmer-Bartoschek","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"issue":"40","key":"10.1016\/j.jinorgbio.2026.113315_bb0430","doi-asserted-by":"crossref","first-page":"17614","DOI":"10.1002\/anie.202006392","article-title":"Stimuli-responsive cycloaurated \u201cOFF-ON\u201d switchable anion transporters","volume":"59","author":"Fares","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"issue":"24","key":"10.1016\/j.jinorgbio.2026.113315_bb0435","doi-asserted-by":"crossref","first-page":"13405","DOI":"10.1002\/anie.202102266","article-title":"Interfering with metabolic profile of triple-negative breast cancers using rationally designed metformin prodrugs","volume":"60","author":"Babak","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"issue":"3","key":"10.1016\/j.jinorgbio.2026.113315_bb0440","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1039\/D2SC04707A","article-title":"The anti-breast cancer stem cell properties of gold(i)-non-steroidal anti-inflammatory drug complexes","volume":"14","author":"Johnson","year":"2023","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0445","series-title":"Ligand Design in Medicinal Inorganic Chemistry","first-page":"227","article-title":"Therapeutic gold compounds","author":"Berners-Price","year":"2014"},{"issue":"46","key":"10.1016\/j.jinorgbio.2026.113315_bb0450","doi-asserted-by":"crossref","first-page":"11840","DOI":"10.1002\/chem.201800981","article-title":"Gold(III) complexes for antitumor applications: An overview","volume":"24","author":"Bertrand","year":"2018","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0455","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ccr.2019.02.027","article-title":"Advances in diphosphine ligand-containing gold complexes as anticancer agents","volume":"388","author":"Mirzadeh","year":"2019","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2021.213905","article-title":"Proteomics as a tool to disclose the cellular and molecular mechanisms of selected anticancer gold compounds","volume":"438","author":"Gamberi","year":"2021","journal-title":"Coord. Chem. Rev."},{"issue":"13","key":"10.1016\/j.jinorgbio.2026.113315_bb0465","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1039\/D1CS00933H","article-title":"Recent development of gold(i) and gold(iii) complexes as therapeutic agents for cancer diseases","volume":"51","author":"Lu","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2022.214836","article-title":"Selenol (-SeH) as a target for mercury and gold in biological systems: contributions of mass spectrometry and atomic spectroscopy","volume":"474","author":"Bernabeu de Maria","year":"2023","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2022.102250","article-title":"Promising heterometallic compounds as anticancer agents: recent studies in vivo","volume":"72","author":"L\u00f3pez-Hern\u00e1ndez","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"9","key":"10.1016\/j.jinorgbio.2026.113315_bb0480","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1021\/acs.accounts.3c00037","article-title":"Modulating the chemical reactivity of gold complexes in living systems: from concept to biomedical applications","volume":"56","author":"Jiang","year":"2023","journal-title":"Acc. Chem. Res."},{"issue":"18","key":"10.1016\/j.jinorgbio.2026.113315_bb0485","doi-asserted-by":"crossref","first-page":"15719","DOI":"10.1021\/jacs.5c03186","article-title":"Subcellular photocatalysis enables tumor-targeted inhibition of Thioredoxin reductase I by Organogold(I) complexes","volume":"147","author":"Liu","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"23","key":"10.1016\/j.jinorgbio.2026.113315_bb0490","doi-asserted-by":"crossref","first-page":"10407","DOI":"10.1021\/jacs.2c02435","article-title":"Target profiling of an iridium(III)-based immunogenic cell death inducer unveils the engagement of unfolded protein response regulator BiP","volume":"144","author":"Xiong","year":"2022","journal-title":"J. Am. Chem. Soc."},{"issue":"18","key":"10.1016\/j.jinorgbio.2026.113315_bb0495","doi-asserted-by":"crossref","first-page":"15216","DOI":"10.1021\/jacs.5c00255","article-title":"Oxoisoaporphine alkaloid iridium(III) derivative: an immunogenic cell death inducer that engages the autophagy-dependent regulator Cathepsin D","volume":"147","author":"Lu","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"9","key":"10.1016\/j.jinorgbio.2026.113315_bb0500","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1039\/c1mt00062d","article-title":"Gold compounds as therapeutic agents for human diseases","volume":"3","author":"Berners-Price","year":"2011","journal-title":"Metallomics"},{"issue":"3","key":"10.1016\/j.jinorgbio.2026.113315_bb0505","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/med.20168","article-title":"Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies","volume":"30","author":"Nobili","year":"2010","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0510","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cbpa.2017.10.014","article-title":"Anticancer metal-N-heterocyclic carbene complexes of gold, platinum and palladium","volume":"43","author":"Zou","year":"2018","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"5795","key":"10.1016\/j.jinorgbio.2026.113315_bb0515","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0140-6736(00)82169-8","article-title":"Rheumatoid arthritis and its treatment by gold salts","volume":"224","author":"Forestier","year":"1934","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jinorgbio.2026.113315_bb0520","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10787-007-0021-x","article-title":"Clinical pharmacology of gold","volume":"16","author":"Kean","year":"2008","journal-title":"Inflammopharmacology"},{"issue":"11","key":"10.1016\/j.jinorgbio.2026.113315_bb0525","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/antiox14111351","article-title":"Anti-Tumoral treatment with Thioredoxin reductase 1 inhibitor Auranofin fosters regulatory T cell and B16F10 expansion in mice","volume":"14","author":"Bonner","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0530","doi-asserted-by":"crossref","unstructured":"Cai, W.; Zhang, L.; Song, Y.; Wang, B.; Zhang, B.; Cui, X.; Hu, G.; Liu, Y.; Wu, J. Fang, J., Small molecule inhibitors of mammalian thioredoxin reductase. Free Radic. Biol. Med. 2012, 52(2), 257\u2013265.","DOI":"10.1016\/j.freeradbiomed.2011.10.447"},{"issue":"6","key":"10.1016\/j.jinorgbio.2026.113315_bb0535","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bbagen.2009.01.014","article-title":"Focus on mammalian thioredoxin reductases \u2014 important selenoproteins with versatile functions","volume":"1790","author":"Arn\u00e9r","year":"2009","journal-title":"BBA - Gen. Subj."},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105854","article-title":"Thioredoxin reductase as a pharmacological target","volume":"174","author":"Bj\u00f8rklund","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113315_bb0545","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-022-03405-w","article-title":"Mitochondrial TrxR2 regulates metabolism and protects from metabolic disease through enhanced TCA and ETC function","volume":"5","author":"Chocron","year":"2022","journal-title":"Commun. Biol."},{"issue":"25","key":"10.1016\/j.jinorgbio.2026.113315_bb0550","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1161\/CIRCULATIONAHA.111.059253","article-title":"Mitochondrial thioredoxin reductase is essential for early postischemic myocardial protection","volume":"124","author":"Horstkotte","year":"2011","journal-title":"Circulation"},{"issue":"428","key":"10.1016\/j.jinorgbio.2026.113315_bb0555","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf7444","article-title":"Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy","volume":"10","author":"Stafford","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.jinorgbio.2026.113315_bb0560","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1921828118","article-title":"The mitochondrial thioredoxin reductase system (TrxR2) in vascular endothelium controls peroxynitrite levels and tissue integrity","volume":"118","author":"Kameritsch","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"40","key":"10.1016\/j.jinorgbio.2026.113315_bb0565","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202205900","article-title":"Stimuli-responsive metal complexes for biomedical applications","volume":"61","author":"Amarsy","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"issue":"2","key":"10.1016\/j.jinorgbio.2026.113315_bb0570","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1021\/acs.chemrev.8b00209","article-title":"Stimuli-responsive therapeutic metallodrugs","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."},{"issue":"9","key":"10.1016\/j.jinorgbio.2026.113315_bb0575","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202423335","article-title":"Advances in the Design of Photoactivatable Metallodrugs: excited state Metallomics","volume":"64","author":"Shi","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113315_bb0580","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/anie.201905171","article-title":"New designs for phototherapeutic transition metal complexes","volume":"59","author":"Imberti","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"issue":"16","key":"10.1016\/j.jinorgbio.2026.113315_bb0585","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1021\/acs.accounts.5c00455","article-title":"In-cell NAD(P)H photocatalysis with a metal complex for photocatalytic anticancer therapy","volume":"58","author":"Wei","year":"2025","journal-title":"Acc. Chem. Res."},{"issue":"7","key":"10.1016\/j.jinorgbio.2026.113315_bb0590","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/s41557-023-01199-w","article-title":"In vivo metallophilic self-assembly of a light-activated anticancer drug","volume":"15","author":"Zhou","year":"2023","journal-title":"Nat. Chem."},{"issue":"8","key":"10.1016\/j.jinorgbio.2026.113315_bb0595","article-title":"A carbonic anhydrase IX (CAIX)-anchored rhenium(I) photosensitizer evokes pyroptosis for enhanced anti-tumor immunity","volume":"61","author":"Su","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113315_bb0600","article-title":"Golgi apparatus-targeted aggregation-induced emission luminogens for effective cancer photodynamic therapy","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.jinorgbio.2026.113315_bb0605","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1039\/D3CS00456B","article-title":"Mitochondria-targeted BODIPY dyes for small molecule recognition, bio-imaging and photodynamic therapy","volume":"53","author":"Wang","year":"2024","journal-title":"Chem. Soc. Rev."},{"issue":"11","key":"10.1016\/j.jinorgbio.2026.113315_bb0610","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41557-019-0328-4","article-title":"Targeted photoredox catalysis in cancer cells","volume":"11","author":"Huang","year":"2019","journal-title":"Nat. Chem."},{"issue":"16","key":"10.1016\/j.jinorgbio.2026.113315_bb0615","doi-asserted-by":"crossref","first-page":"10135","DOI":"10.1021\/acs.chemrev.3c00161","article-title":"Metal-based photosensitizers as inducers of regulated cell death mechanisms","volume":"123","author":"Zhang","year":"2023","journal-title":"Chem. Rev."},{"issue":"27","key":"10.1016\/j.jinorgbio.2026.113315_bb0620","doi-asserted-by":"crossref","first-page":"11046","DOI":"10.1002\/anie.202000528","article-title":"Cyclometalated gold(III)-hydride complexes exhibit visible light-induced thiol reactivity and act as potent photo-activated anti-Cancer agents","volume":"59","author":"Luo","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"issue":"16","key":"10.1016\/j.jinorgbio.2026.113315_bb0625","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202201103","article-title":"Alkylgold(III) complexes undergo unprecedented photo-induced \u03b2-hydride elimination and reduction for targeted cancer therapy","volume":"61","author":"Jiang","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"issue":"45","key":"10.1016\/j.jinorgbio.2026.113315_bb0630","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202212689","article-title":"Organogold(III) complexes display conditional photoactivities: evolving from photodynamic into photoactivated chemotherapy in response to O(2) consumption for robust cancer therapy","volume":"61","author":"Luo","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"issue":"7","key":"10.1016\/j.jinorgbio.2026.113315_bb0635","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41557-022-00911-6","article-title":"Ion-pair reorganization regulates reactivity in photoredox catalysts","volume":"14","author":"Earley","year":"2022","journal-title":"Nat. Chem."},{"issue":"28","key":"10.1016\/j.jinorgbio.2026.113315_bb0640","doi-asserted-by":"crossref","first-page":"15049","DOI":"10.1021\/jacs.3c03625","article-title":"Ion pairing of cationic and anionic Ir(III) photosensitizers for photocatalytic CO2 reduction at lipid\u2013membrane surfaces","volume":"145","author":"Takizawa","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113315_bb0645","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/anie.201809601","article-title":"Bioinspired radical Stetter reaction: radical umpolung enabled by ion-pair photocatalysis","volume":"58","author":"Morack","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113315_bb0650","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1021\/acs.chemrev.7b00305","article-title":"Electrostatic interactions in protein structure, folding, binding, and condensation","volume":"118","author":"Zhou","year":"2018","journal-title":"Chem. Rev."},{"issue":"12","key":"10.1016\/j.jinorgbio.2026.113315_bb0655","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.1021\/jacs.4c00408","article-title":"Ion pairing enables targeted prodrug activation via red light photocatalysis: a proof-of-concept study with anticancer gold complexes","volume":"146","author":"Xie","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"18","key":"10.1016\/j.jinorgbio.2026.113315_bb0660","doi-asserted-by":"crossref","first-page":"10082","DOI":"10.1021\/jacs.3c00254","article-title":"Photoactivation of Boronic acid prodrugs via a phenyl radical mechanism: iridium(III) anticancer complex as an example","volume":"145","author":"Liu","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.jinorgbio.2026.113315_bb0665","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1021\/acs.chemrev.2c00649","article-title":"Next generation gold drugs and probes: chemistry and biomedical applications","volume":"123","author":"Mertens","year":"2023","journal-title":"Chem. Rev."},{"issue":"2","key":"10.1016\/j.jinorgbio.2026.113315_bb0670","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nchem.2888","article-title":"Decarboxylative alkylation for site-selective bioconjugation of native proteins via oxidation potentials","volume":"10","author":"Bloom","year":"2018","journal-title":"Nat. Chem."},{"issue":"8","key":"10.1016\/j.jinorgbio.2026.113315_bb0675","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.chempr.2022.04.016","article-title":"Spatially resolved cell tagging and surfaceome labeling via targeted photocatalytic decaging","volume":"8","author":"Liu","year":"2022","journal-title":"Chem"},{"issue":"2","key":"10.1016\/j.jinorgbio.2026.113315_bb0680","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1021\/jacs.3c09545","article-title":"Photocatalytic activation of aryl(trifluoromethyl) Diazos to Carbenes for high-resolution protein labeling with red light","volume":"146","author":"Cabanero","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.jinorgbio.2026.113315_bb0685","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1021\/jacs.3c13647","article-title":"Intracellular synthesis of indoles enabled by visible-light photocatalysis","volume":"146","author":"D\u2019Avino","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.jinorgbio.2026.113315_bb0690","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccell.2014.11.019","article-title":"Glutathione and Thioredoxin antioxidant pathways synergize to drive cancer initiation and progression","volume":"27","author":"Harris","year":"2015","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.jinorgbio.2026.113315_bb0695","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ccell.2016.02.012","article-title":"Protein Kinase C&#x3b9; Drives a NOTCH3-dependent Stem-like Phenotype in Mutant <em>KRAS<\/em> Lung Adenocarcinoma","volume":"29","author":"Ali","year":"2016","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.jinorgbio.2026.113315_bb0700","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","article-title":"Oxidative stress in Cancer","volume":"38","author":"Hayes","year":"2020","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.jinorgbio.2026.113315_bb0705","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/jnci\/djy149","article-title":"Auranofin\/vitamin C: a novel drug combination targeting triple-negative breast Cancer","volume":"111","author":"Hatem","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113315_bb0710","doi-asserted-by":"crossref","DOI":"10.1002\/hep.30467","article-title":"Induction of oxidative stress through inhibition of Thioredoxin reductase 1 is an effective therapeutic approach for hepatocellular carcinoma","volume":"69","author":"Lee","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215323","article-title":"Molecular mechanisms and clinical implications of the gold drug auranofin","volume":"493","author":"Shen","year":"2023","journal-title":"Coord. Chem. Rev."},{"issue":"3","key":"10.1016\/j.jinorgbio.2026.113315_bb0720","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/med.21872","article-title":"Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness","volume":"42","author":"Gamberi","year":"2022","journal-title":"Med. Res. Rev."},{"issue":"6","key":"10.1016\/j.jinorgbio.2026.113315_bb0725","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0006-2952(86)90078-X","article-title":"Cellular association, intracellular distribution, and efflux of auranofin via sequential ligand exchange reactions","volume":"35","author":"Snyder","year":"1986","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.jinorgbio.2026.113315_bb0730","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0162-0134(87)80062-4","article-title":"Thiol competition for Et3PAuS-albumin: a nonenzymatic mechanism for Et3PO formation","volume":"30","author":"Coffer","year":"1987","journal-title":"J. Inorg. Biochem."},{"issue":"2","key":"10.1016\/j.jinorgbio.2026.113315_bb0735","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1021\/ic9414280","article-title":"Kinetics and mechanism of the reaction between serum albumin and Auranofin (and its isopropyl analogue) in vitro","volume":"35","author":"Roberts","year":"1996","journal-title":"Inorg. Chem."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113315_bb0740","first-page":"94","article-title":"Screening trial with the coordinated gold compound auranofin using mouse lymphocyte leukemia P388","volume":"41","author":"Simon","year":"1981","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113315_bb0745","first-page":"32","article-title":"Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models","volume":"45","author":"Mirabelli","year":"1985","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.jinorgbio.2026.113315_bb0750","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1182\/blood.V122.21.3819.3819","article-title":"Auranofin induces a reversible in-vivo stress response that correlates with a transient clinical effect in patients with chronic lymphocytic leukemia","volume":"122","author":"Saba","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113315_bb0755","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nutres.2004.12.009","article-title":"Treatment of hyperlipoproteinemia with pantethine: a review and analysis of efficacy and tolerability","volume":"25","author":"McRae","year":"2005","journal-title":"Nutr. Res."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113315_bb0760","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1158\/0008-5472.CAN-18-1938","article-title":"Inhibition of Thioredoxin\/Thioredoxin reductase induces synthetic lethality in lung cancers with compromised glutathione homeostasis","volume":"79","author":"Yan","year":"2019","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113315_bb0765","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ijc.32410","article-title":"Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer","volume":"146","author":"Raninga","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"671","key":"10.1016\/j.jinorgbio.2026.113315_bb0770","doi-asserted-by":"crossref","first-page":"eabq5931","DOI":"10.1126\/scitranslmed.abq5931","article-title":"Protein kinase C\u03b9 mediates immunosuppression in lung adenocarcinoma","volume":"14","author":"Yin","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0775","doi-asserted-by":"crossref","unstructured":"L. Gottlieb, N., Pharmacology of Auranofin: overview and update. Scand. J. Rheumatol. 1986, 15(sup63), 19\u201328.","DOI":"10.1080\/15027732.1986.12461436"},{"issue":"6","key":"10.1016\/j.jinorgbio.2026.113315_bb0780","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/nm.2758","article-title":"A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target","volume":"18","author":"Debnath","year":"2012","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.jinorgbio.2026.113315_bb0785","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrm.2016.110","article-title":"Coenzyme a: to make it or uptake it?","volume":"17","author":"Sibon","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0790","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.00543","article-title":"Recent advances of gold compounds in anticancer immunity","volume":"8","author":"Yue","year":"2020","journal-title":"Front. Chem."},{"issue":"22","key":"10.1016\/j.jinorgbio.2026.113315_bb0795","doi-asserted-by":"crossref","first-page":"8113","DOI":"10.1039\/D0CS00259C","article-title":"Endoplasmic reticulum stress: an arising target for metal-based anticancer agents","volume":"49","author":"King","year":"2020","journal-title":"Chem. Soc. Rev."},{"issue":"n\/a","key":"10.1016\/j.jinorgbio.2026.113315_bb0800","article-title":"Boosting cancer chemoimmunotherapy with mitochondria-targeting iridium(III)-based immunogenic oncosis inducers","volume":"n\/a","author":"Shu","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102277","article-title":"Immunogenic cell death-inducing metal complexes: from the benchtop to the clinic","volume":"73","author":"Sen","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113315_bb0810","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1039\/D1CS00417D","article-title":"Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future","volume":"51","author":"Sen","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"21","key":"10.1016\/j.jinorgbio.2026.113315_bb0815","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202300662","article-title":"Immunogenic cell death inducing metal complexes for Cancer therapy","volume":"62","author":"Zhang","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"issue":"15","key":"10.1016\/j.jinorgbio.2026.113315_bb0820","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1039\/D4SC08495K","article-title":"Metal-based immunogenic cell death inducers for cancer immunotherapy","volume":"16","author":"Zou","year":"2025","journal-title":"Chem. Sci."},{"issue":"2","key":"10.1016\/j.jinorgbio.2026.113315_bb0825","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1021\/jacs.5c18904","article-title":"Organoplatinum(II) type II immunogenic cell death inducers target protein tyrosine phosphatase 1B to drive immunogenicity","volume":"148","author":"Zou","year":"2026","journal-title":"J. Am. Chem. Soc."},{"issue":"27","key":"10.1016\/j.jinorgbio.2026.113315_bb0830","doi-asserted-by":"crossref","first-page":"23574","DOI":"10.1021\/jacs.5c03455","article-title":"Long-lived immunogenic cell death induced by a water-soluble redox active au(I) Bis-N-heterocyclic Carbene","volume":"147","author":"Levine","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"8","key":"10.1016\/j.jinorgbio.2026.113315_bb0835","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1039\/D2CS00757F","article-title":"Organometallic anti-tumor agents: targeting from biomolecules to dynamic bioprocesses","volume":"52","author":"Peng","year":"2023","journal-title":"Chem. Soc. Rev."},{"issue":"36","key":"10.1016\/j.jinorgbio.2026.113315_bb0840","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202305645","article-title":"Organic-platinum hybrids for covalent binding of G-quadruplexes: structural basis and application to cancer immunotherapy","volume":"62","author":"Liu","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"issue":"27","key":"10.1016\/j.jinorgbio.2026.113315_bb0845","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202507186","article-title":"Metal complexes stimulating immunogenic pyroptosis as burgeoning antitumor strategy","volume":"64","author":"Zheng","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113315_bb0850","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","article-title":"Immunogenic cell stress and death","volume":"23","author":"Kroemer","year":"2022","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.jinorgbio.2026.113315_bb0855","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0860","doi-asserted-by":"crossref","unstructured":"Galluzzi, L.; Kepp, O.; Zitvogel, L.; Tang, D. Kroemer, G., Cancer cell death: cell-autonomous and immunogenic dimensions. Cancer Cell, doi:https:\/\/doi.org\/10.1016\/j.ccell.2025.12.005.","DOI":"10.1016\/j.ccell.2025.12.005"},{"issue":"12","key":"10.1016\/j.jinorgbio.2026.113315_bb0865","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113315_bb0870","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nri.2017.9","article-title":"Dying cells actively regulate adaptive immune responses","volume":"17","author":"Yatim","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.jinorgbio.2026.113315_bb0875","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0880","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.jinorgbio.2026.113315_bb0885","first-page":"187","article-title":"Immunosurveillance in clinical cancer management","volume":"74","author":"Kroemer","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113315_bb0890","doi-asserted-by":"crossref","first-page":"2219591","DOI":"10.1080\/2162402X.2023.2219591","article-title":"Trial watch: chemotherapy-induced immunogenic cell death in oncology","volume":"12","author":"Sprooten","year":"2023","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113315_bb0895","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41423-024-01245-8","article-title":"Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors","volume":"22","author":"Catanzaro","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113315_bb0900","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc3701","article-title":"Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential","volume":"14","author":"Lee","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"30","key":"10.1016\/j.jinorgbio.2026.113315_bb0905","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2412246122","article-title":"Stress-induced translocation of the endoplasmic reticulum chaperone GRP78\/BiP and its impact on human disease and therapy","volume":"122","author":"Lee","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0910","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.canlet.2017.07.009","article-title":"Sensitivity towards the GRP78 inhibitor KP1339\/IT-139 is characterized by apoptosis induction via caspase 8 upon disruption of ER homeostasis","volume":"404","author":"Schoenhacker-Alte","year":"2017","journal-title":"Cancer Lett."},{"issue":"24","key":"10.1016\/j.jinorgbio.2026.113315_bb0915","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2404668121","article-title":"Cu(II) complex that synergistically potentiates cytotoxicity and an antitumor immune response by targeting cellular redox homeostasis","volume":"121","author":"Huang","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"16","key":"10.1016\/j.jinorgbio.2026.113315_bb0920","doi-asserted-by":"crossref","first-page":"13778","DOI":"10.1021\/acs.jmedchem.4c00583","article-title":"Rhodium(III) complex noncanonically potentiates antitumor immune responses by inhibiting Wnt\/\u03b2-catenin signaling","volume":"67","author":"Wang","year":"2024","journal-title":"J. Med. Chem."},{"issue":"17","key":"10.1016\/j.jinorgbio.2026.113315_bb0925","doi-asserted-by":"crossref","first-page":"7803","DOI":"10.1021\/jacs.0c00221","article-title":"A Photocaged, water-oxidizing, and nucleolus-targeted Pt(IV) complex with a distinct anticancer mechanism","volume":"142","author":"Deng","year":"2020","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"10.1016\/j.jinorgbio.2026.113315_bb0930","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm.3708","article-title":"Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy","volume":"20","author":"Sistigu","year":"2014","journal-title":"Nat. Med."},{"issue":"43","key":"10.1016\/j.jinorgbio.2026.113315_bb0935","doi-asserted-by":"crossref","first-page":"19070","DOI":"10.1002\/anie.202008604","article-title":"PlatinER: a highly potent anticancer platinum(II) complex that induces endoplasmic reticulum stress driven immunogenic cell death","volume":"59","author":"Tham","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"issue":"9","key":"10.1016\/j.jinorgbio.2026.113315_bb0940","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1002\/anie.202013987","article-title":"An ER-targeting iridium(III) complex that induces immunogenic cell death in non-small-cell lung cancer","volume":"60","author":"Wang","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"issue":"16","key":"10.1016\/j.jinorgbio.2026.113315_bb0945","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202115247","article-title":"Ferroptosis-enhanced Cancer immunity by a ferrocene-appended iridium(III) Diphosphine complex","volume":"61","author":"Wang","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"issue":"31","key":"10.1016\/j.jinorgbio.2026.113315_bb0950","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202405679","article-title":"A cyclometalated ruthenium(II) complex induces oncosis for synergistic activation of innate and adaptive immunity","volume":"63","author":"Feng","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"issue":"13","key":"10.1016\/j.jinorgbio.2026.113315_bb0955","doi-asserted-by":"crossref","first-page":"8991","DOI":"10.1021\/jacs.3c13224","article-title":"Augmenting Cancer therapy with a supramolecular immunogenic cell death inducer: a lysosome-targeted NIR-light-activated ruthenium(II) Metallacycle","volume":"146","author":"Tu","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.jinorgbio.2026.113315_bb0960","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1039\/c9mt00051h","article-title":"First-in-class ruthenium anticancer drug (KP1339\/IT-139) induces an immunogenic cell death signature in colorectal spheroids in vitro","volume":"11","author":"Wernitznig","year":"2019","journal-title":"Metallomics"},{"issue":"12","key":"10.1016\/j.jinorgbio.2026.113315_bb0965","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1039\/d0mt00227e","article-title":"Plecstatin-1 induces an immunogenic cell death signature in colorectal tumour spheroids","volume":"12","author":"Wernitznig","year":"2020","journal-title":"Metallomics"},{"issue":"9","key":"10.1016\/j.jinorgbio.2026.113315_bb0970","doi-asserted-by":"crossref","first-page":"7908","DOI":"10.1021\/jacs.4c17966","article-title":"Leveraging immunogenic cell death to enhance the immune response against malignant pleural mesothelioma tumors","volume":"147","author":"Chang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113315_bb0975","doi-asserted-by":"crossref","first-page":"8187","DOI":"10.1038\/s41467-024-52458-4","article-title":"Strategically engineered au(I) complexes for orchestrated tumor eradication via chemo-phototherapy and induced immunogenic cell death","volume":"15","author":"Feng","year":"2024","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.jinorgbio.2026.113315_bb0980","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1021\/acs.jmedchem.2c01798","article-title":"Tumor-targeting NHC-au(I) complex induces immunogenic cell death in hepatocellular carcinoma","volume":"66","author":"Yang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113315_bb0985","article-title":"Beyond thiol-enzyme inhibition: sterically bulky NHC-au(I) complexes are catalytically active anticancer agents with reprogrammed immunomodulatory function","author":"Zhong","year":"2026","journal-title":"J. Am. Chem. Soc."},{"issue":"7","key":"10.1016\/j.jinorgbio.2026.113315_bb0990","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.31635\/ccschem.021.202101212","article-title":"Anion-responsive manganese porphyrin facilitates chloride transport and induces immunogenic cell death","volume":"4","author":"Wang","year":"2022","journal-title":"CCS Chem."},{"issue":"15","key":"10.1016\/j.jinorgbio.2026.113315_bb0995","doi-asserted-by":"crossref","first-page":"10497","DOI":"10.1021\/acs.jmedchem.3c00603","article-title":"Potent zinc(II)-based immunogenic cell death inducer triggered by ROS-mediated ERS and mitochondrial ca(2+) overload","volume":"66","author":"Liao","year":"2023","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.jinorgbio.2026.113315_bb1000","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004458","article-title":"Targeting of Nrf2 improves antitumoral responses by human NK cells, TIL and CAR T cells during oxidative stress","volume":"10","author":"Renken","year":"2022","journal-title":"J. Immunother. Cancer"}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013426001042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013426001042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:43:42Z","timestamp":1779252222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0162013426001042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":200,"alternative-id":["S0162013426001042"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2026.113315","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticancer gold complexes: Controlled activation, precision targeting and beyond","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2026.113315","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113315"}}